Phase 2 Readout
OSTX: Phase 2 Readout: ost-her2
September 1, 2026 · ost-her2. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- September 1, 2026
- Company
- OS Therapies Inc (OSTX)
- Drug
- ost-her2
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout
Phase 2 Readout: ost-her2
- Company
- OS Therapies Inc (OSTX)
- Drug
- ost-her2
- Indication
- Pulmonary Metastatic Osteosarcoma